Skip to main content
Glama

Temperature Random

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "drug"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.4/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/openWorld/idempotent annotations, the description discloses substantial behavioral detail: identifiers that cannot be resolved are listed under `unresolved` rather than omitted, ambiguous matches return `figi_candidates` and assert nothing, LEI/FIGI enrichment degrades gracefully when upstream sources are unavailable, and multiple internal lookups are cascaded. This goes well beyond what annotations already provide and contradicts nothing.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with a strong purpose statement and usage directive, and the detailed content is genuinely valuable. However, it is extremely dense, with long parenthetical chains and semicolon-heavy sentences that would be far more scannable as bullets or labeled sections. The length is somewhat justified by the tool's complexity, but structure suffers.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex tool with no output schema and only two parameters, the description is remarkably complete. It covers supported entity types, input normalization, ambiguity behavior via `figi_candidates`, explicit `unresolved` reporting, data sources, ownership information, graceful degradation, and drug-result contents. An agent has what it needs to decide when to call, what to pass, and what to expect back.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although schema coverage is 100%, the description adds significant meaning beyond the schema. It introduces ISIN as a valid company input, explains how an ISIN maps to a legal entity, and gives crucial formatting guidance for `value`: pass the issuer name exactly as printed and never the full noun phrase (e.g., not 'revenue bonds'). This materially improves the agent's ability to construct correct calls.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a clear specific verb and resource: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It differentiates itself from identifier-lookup needs by listing concrete example questions, but it does not explicitly name sibling alternatives such as entity_profile or compare_entities, so it falls just short of full sibling differentiation.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives explicit when-to-use guidance: 'Use FIRST whenever you have a name but need an ID.' It also enumerates supported types and accepted input forms (ticker, CIK, ISIN, company name, drug name). However, it does not explicitly state when not to use this tool or name alternative tools, so it lacks the full when/when-not/alternatives structure.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

There are several overlapping clusters: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all route questions through the same 5,743-tool catalog, and ask_pipeworx_beta is currently an exact duplicate of ask_pipeworx. The Polymarket opportunity tools (polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread, bet_research) also have fuzzy boundaries despite detailed descriptions.

Naming Consistency2/5

There is no consistent naming pattern across the set: some tools are verb-first (ask_pipeworx, compare_entities, validate_claim), some are noun-first (entity_profile, recent_changes, polymarket_edges), and some are compound/multi-word oddities (temperature_random_generate, ai_visibility_check). Small internal clusters like remember/recall/forget and subscribe/unsubscribe/list_subscriptions show mini-consistency, but the overall convention is mixed and unpredictable.

Tool Count2/5

With 32 tools, the server is over-stuffed, and many of them serve the same broad Pipeworx data/research purpose while one unrelated temperature tool rides along. The count is above the 25-tool threshold where a set starts to feel unwieldy, and several tools could be merged or dropped without losing real capability.

Completeness4/5

Assuming the intended scope is the Pipeworx data/agent platform implied by 31 of the 32 tools, coverage is strong: lookups, grounded verification, deep research, entity profiles, comparisons, entity resolution, claim validation, tool discovery, memory, subscription lifecycle, prediction-market analysis, execution risk, and feedback are all represented. The temperature_random_generate tool is a domain misfit rather than a completeness gap, and there are few obvious missing operations for the stated workflows.